ATDev Advances Robotic Mobility as SXSW Pitch 2026 Finalist
ATDev has been invited to pitch in the Healthcare, AssistiveTech & BioTech category
The company is working on the development of robotic technologies that can be used to support the mobility and rehabilitation of those with mobility issues, disabilities, and older adults.
ATDev will be displaying its Reflex robotic rehabilitation device on
ATDev is also a subcontractor in the national ARPA-H RAMMP initiative, which is a federal program that aims to accelerate the development of robotic wheelchair technologies.
"We're honored to be selected as a finalist for SXSW Pitch 2026," said
Since 2009, 732 companies have participated in SXSW Pitch, collectively raising over
About ATDev
ATDev, Assistive Technology Development, is an assistive technology and robotics company focused on transforming mobility, independence, and healthcare access through innovation. The company develops human centered technology designed to empower people to live independently, confidently, and without barriers.
ATDev brings together robotics, healthcare, and accessibility to create solutions for people with mobility challenges and rehabilitation needs. Learn more at https://assistivetech.dev.
About SXSW
SXSW dedicates itself to helping creative people achieve their goals. Founded in 1987 in
Media Contact:
Pitch Public Relations
602-309-4286
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/atdev-advances-robotic-mobility-as-sxsw-pitch-2026-finalist-302707160.html
SOURCE ATDev
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Democratic Republic of Congo Launches Landmark "Invest in the DRC" Advertising Campaign in United States
- The Next Crypto Bull Run: How Early Buyers Are Positioning Before It Starts
- Next Crypto to Explode in 2026: Why Pepeto’s Presale Is Outpacing the Competition
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share